Elissa Engel, MD

Articles by Elissa Engel, MD

Dr. Engel on the Future of Eltrombopag in HIV-Related Thrombocytopenia

August 17th 2018

Elissa Engel, MD, pediatric resident, University of South Florida, discusses the future of eltrombopag (Promacta) in HIV-related thrombocytopenia.

Dr. Engel on the Use of Eltrombopag in HIV-Related Thrombocytopenia

ByElissa Engel, MD

May 5th 2018

Elissa Engel, MD, pediatric resident, University of South Florida, discusses the successful use of eltrombopag (Promacta) in a pediatric patient with HIV-related thrombocytopenia.

Latest Updated Articles

Dr. Engel on the Future of Eltrombopag in HIV-Related Thrombocytopenia
Published: August 17th 2018 | Updated:
Dr. Engel on the Use of Eltrombopag in HIV-Related Thrombocytopenia
Published: May 5th 2018 | Updated:

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD

Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant

Dr Neff on the Accuracy and Feasibility of Self-Collected HPV Testing in Cervical Cancer

Multidisciplinary Breast Cancer Experts Outline Proactive Strategies for Managing Treatment-Related Toxicities: With Neil Iyengar, MD; Heather Moore, CPP, PharmD; and Sarah Donahue, MPH, NP